A Study to Evaluate the Efficacy and Safety of SYHX1901 Tablet in Non-segmental Vitiligo Patients

NCT06511739 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-segmental Vitiligo

Interventions

DRUG: SYHX1901
DRUG: placebo

Sponsor

CSPC Ouyi Pharmaceutical Co., Ltd.

Collaborators

[object Object]